Hemeo

Amsterdam, Netherlands · Founded 2019 · Privately Held (backing)

Developer of a clinical decision support platform designed for blood coagulation management. Hemeo is based in Amsterdam, Netherlands and was founded in 2019. Its last reported valuation was $65.8 million in Oct 2026. It has raised $8.1 million.

Last reported valuation
$65.8M
Oct 2026
Priced at
—
Total raised
$8.1M
Last round
—

Who backs Hemeo?

4 investors
InvestorType
NLC Health VenturesVenture capital
Health Engine Accelerator—
ScaleNL—
Yahara Software—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Hemeo investors

4 investors are on record for Hemeo, including NLC Health Ventures, Health Engine Accelerator, ScaleNL and Yahara Software.

Free account
More of Hemeo with a free account
  • ·Watch Hemeo: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 4 firms already write checks for companies like Hemeo. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View